Home The New Strategic CDMO: End-to-End Solutions for Better and Faster Drug Development
 

Keywords :   


The New Strategic CDMO: End-to-End Solutions for Better and Faster Drug Development

2016-05-17 11:52:14| drugdiscoveryonline News Articles

While Big Pharma historically has kept development activities and CMC management in-house, unpredictable pipelines and increasing drug complexity have compelled the industry to look more seriously at outsourcing drug development and manufacturing to increase productivity and throughput. Bill Weiser, the executive director and global head of analytical sciences at Patheon, discusses how a new generation of CDMOs have positioned themselves to provide more strategic solutions that not only complement product development but also drive therapies to patients faster.

Tags: development solutions drug faster

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Forecast Discussion Number 6
05.11Tropical Storm Rafael Wind Speed Probabilities Number 6
05.11Tropical Storm Rafael Public Advisory Number 6
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Forecast Advisory Number 6
05.11Why colouring clothes has a big environmental impact
05.11Atlantic Tropical Weather Outlook
More »